Roskilde is a city in Denmark, west of Copenhagen. Next to its harbor, the Viking Ship Museum has 11th-century vessels and an active boatyard. In its center, the Gothic, twin-spired Roskilde Cathedral holds the tombs of many Danish kings and queens. The nearby Museum of Contemporary Art sits in a former royal mansion. West of the city, the huge Land of Legends open-air museum recreates Stone Age and Viking life. ― Google

During the past decade, DK-Roskilde-ROSKILDE conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "DK-Roskilde-ROSKILDE" #1 collaborator was "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator, "European Myeloma Network" with 1 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "NMSG (Nordic Myeloma Study Group)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "DK-Roskilde-ROSKILDE" are "CLL" (1 trials), "Chronic Lymphocytic Leukemia in Relapse" (1 trials), "Chronic Lymphocytic Leukemia in Remission" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "DK-Roskilde-ROSKILDE" in a lesser frequency.

Most popular intervention types in "DK-Roskilde-ROSKILDE" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials), "Ibrutinib + Venetoclax 15 cycles" (1 trials) and "Ibrutinib until progression/relapse" (1 trials). Other intervention names were less common.

The vast majority of trials in "DK-Roskilde-ROSKILDE" are 3 trials for "All" genders.

Currently, there are NaN active trials in "DK-Roskilde-ROSKILDE". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in DK-Roskilde-ROSKILDE, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DK-Roskilde-ROSKILDE, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".